Butylphthalide
Sponsors
Jinling Hospital, China, Beijing Tiantan Hospital, Qianfoshan Hospital, Xin Huang, First Affiliated Hospital, Sun Yat-Sen University
Conditions
Acute Ischemic StrokeBrain InfarctionBrain IschemiaCardiovascular DiseasesCentral Nervous System DiseasesCerebral InfarctionCerebral Small Vessel DiseasesCognitive Impairment
Phase 3
Butylphthalide for Preventing Restenosis After Intracranial and Extracranial Artery Stenting
CompletedNCT01405248
Start: 2011-07-31End: 2014-01-31Updated: 2015-10-26
Efficacy and Safety of Butylphthalide for Acute Ischemic Stroke Patients Receiving Intravenous Thrombolysis or Endovascular Treatment
CompletedNCT03539445
Start: 2018-07-01End: 2022-07-31Updated: 2022-08-05
A Randomized Controlled Trial on the Efficacy and Safety of Butylphthalide in Reducing Myocardial Infarction Size and Improving Outcomes in STEMI Patients After Primary PCI
Not yet recruitingNCT06704685
Start: 2024-12-01End: 2025-12-31Target: 40Updated: 2024-11-26
Butylphthalide for Long-term Efficacy in Minor Stroke Study
Not yet recruitingNCT07230587
Start: 2025-12-01End: 2028-10-01Target: 1200Updated: 2025-11-17
Isosorbide Mononitrate and Butylphthalide to Reduce the Risk of Disability in Patients With Acute Lacunar Stroke (IMPACT)
Not yet recruitingNCT07252544
Start: 2025-12-01End: 2028-02-29Target: 3156Updated: 2025-11-26
Phase 4
For Patients With Ischemic Stroke, Clinically Study the Effectiveness and Safety of Butylphthalide.
RecruitingNCT05068349
Start: 2022-05-07End: 2025-12-31Target: 300Updated: 2024-04-09
Butylphthalide for Cognitive Impairment in Elderly Patients With Focal Epilepsy
RecruitingNCT07193277
Start: 2025-09-01End: 2028-09-01Target: 220Updated: 2025-09-25
Unknown Phase
Using Real-world Evidence to Analyze the Clinical Effects and Adverse Events of Butylphthalide in Stroke Patients
CompletedNCT05086874
Start: 2022-05-07End: 2023-03-01Updated: 2024-04-09
Efficacy of Butylphthalide on Symptomatic Atherosclerotic Stenosis in Middle Cerebral Artery
Not yet recruitingNCT06331494
Start: 2024-03-15End: 2026-08-31Target: 140Updated: 2024-03-26